PARMAXPharmaceuticals
Parmax Pharma Ltd — Balance Sheet
₹28.44
-9.12%
Parmax Pharma Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Ordinary Shares Number | 0.37 Cr | 0.37 Cr | 0.37 Cr | 0.37 Cr | — |
| Share Issued | 0.37 Cr | 0.37 Cr | 0.37 Cr | 0.37 Cr | — |
| Net Debt | 7.61 Cr | 5.86 Cr | 5.18 Cr | 4.34 Cr | — |
| Total Debt | 7.70 Cr | 5.91 Cr | 5.37 Cr | 5.18 Cr | — |
| Tangible Book Value | -1.99 Cr | 0.07 Cr | 5.86 Cr | 5.96 Cr | — |
| Invested Capital | 5.71 Cr | 5.98 Cr | 11.23 Cr | 11.14 Cr | — |
| Working Capital | -3.03 Cr | -3.44 Cr | 0.39 Cr | -0.75 Cr | — |
| Net Tangible Assets | -1.99 Cr | 0.07 Cr | 5.86 Cr | 5.96 Cr | — |
| Common Stock Equity | -1.99 Cr | 0.07 Cr | 5.86 Cr | 5.96 Cr | — |
| Total Capitalization | 5.71 Cr | 5.98 Cr | 10.33 Cr | 10.48 Cr | — |
| Total Equity Gross Minority Interest | -1.99 Cr | 0.07 Cr | 5.86 Cr | 5.96 Cr | — |
| Stockholders Equity | -1.99 Cr | 0.07 Cr | 5.86 Cr | 5.96 Cr | — |
| Other Equity Interest | -6.44 Cr | -4.35 Cr | 1.40 Cr | 1.51 Cr | — |
| Capital Stock | 4.45 Cr | 4.45 Cr | 4.45 Cr | 4.45 Cr | — |
| Common Stock | 4.45 Cr | 4.45 Cr | 4.45 Cr | 4.45 Cr | — |
| Total Liabilities Net Minority Interest | 20.74 Cr | 15.26 Cr | 11.76 Cr | 12.01 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 7.70 Cr | 6.05 Cr | 4.62 Cr | 4.70 Cr | — |
| Long Term Debt And Capital Lease Obligation | 7.70 Cr | 5.91 Cr | 4.48 Cr | 4.52 Cr | — |
| Long Term Debt | 7.70 Cr | 5.91 Cr | 4.48 Cr | 4.52 Cr | — |
| Current Liabilities | 13.04 Cr | 9.21 Cr | 7.14 Cr | 7.31 Cr | — |
| Other Current Liabilities | 2.24 Cr | 1.34 Cr | 0.57 Cr | 0.20 Cr | — |
| Current Debt And Capital Lease Obligation | 0.00 | 0.00 | 0.89 Cr | 0.66 Cr | — |
| Current Debt | 0.00 | 0.00 | 0.89 Cr | 0.66 Cr | — |
| Current Provisions | 0.59 Cr | 0.14 Cr | 0.52 Cr | 0.48 Cr | — |
| Payables | 10.22 Cr | 7.47 Cr | 4.93 Cr | 5.75 Cr | — |
| Total Tax Payable | 0.00 | 0.08 Cr | 0.27 Cr | 0.23 Cr | — |
| Accounts Payable | 10.22 Cr | 7.39 Cr | 4.66 Cr | 5.52 Cr | — |
| Total Assets | 18.75 Cr | 15.33 Cr | 17.61 Cr | 17.97 Cr | — |
| Total Non Current Assets | 8.75 Cr | 9.56 Cr | 10.08 Cr | 11.42 Cr | — |
| Non Current Deferred Taxes Assets | 0.19 Cr | 0.00 | 0.00 | 0.00 | — |
| Investmentin Financial Assets | 0.40 Cr | 6000.00 | 6000.00 | 6000.00 | — |
| Investment Properties | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Goodwill And Other Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net PPE | 7.97 Cr | 9.38 Cr | 9.50 Cr | 10.44 Cr | — |
| Gross PPE | 7.97 Cr | 19.97 Cr | 18.38 Cr | 17.45 Cr | — |
| Construction In Progress | 0.00 | 0.10 Cr | 0.00 | 0.00 | — |
| Other Properties | 7.97 Cr | 2.17 Cr | 2.08 Cr | 1.97 Cr | — |
| Current Assets | 10.00 Cr | 5.77 Cr | 7.53 Cr | 6.56 Cr | — |
| Inventory | 3.31 Cr | 2.39 Cr | 4.31 Cr | 2.85 Cr | — |
| Other Receivables | 5.32 Cr | 1.32 Cr | 2.18 Cr | 1.66 Cr | — |
| Taxes Receivable | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Accounts Receivable | 1.28 Cr | 1.82 Cr | 0.62 Cr | 0.68 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 0.09 Cr | 0.05 Cr | 0.19 Cr | 0.84 Cr | — |
| Cash And Cash Equivalents | 0.09 Cr | 0.05 Cr | 0.19 Cr | 0.84 Cr | — |
| Retained Earnings | — | -4.38 Cr | 1.40 Cr | 1.51 Cr | 1.37 Cr |
| Other Non Current Liabilities | — | -3.76 | 0.54 | 1.00 | 4.00 |
| Non Current Deferred Taxes Liabilities | — | 0.14 Cr | 0.14 Cr | 0.18 Cr | 0.23 Cr |
| Current Deferred Taxes Liabilities | — | 0.00 | 0.19 Cr | 0.23 Cr | 0.28 Cr |
| Other Non Current Assets | — | 1.75 | 0.40 Cr | 0.79 Cr | 1.39 Cr |
| Non Current Prepaid Assets | — | 0.18 Cr | 0.19 Cr | 0.18 Cr | 0.16 Cr |
| Other Investments | — | 6000.00 | — | — | 6000.00 |
| Held To Maturity Securities | — | 6000.00 | 6000.00 | 6000.00 | 6000.00 |
| Accumulated Depreciation | — | -10.60 Cr | -8.88 Cr | -7.00 Cr | -5.07 Cr |
| Machinery Furniture Equipment | — | 15.73 Cr | 14.33 Cr | 13.52 Cr | 12.17 Cr |
| Buildings And Improvements | — | 1.77 Cr | 1.76 Cr | 1.75 Cr | 1.64 Cr |
| Land And Improvements | — | 0.21 Cr | 0.21 Cr | 0.21 Cr | 0.21 Cr |
| Properties | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | — | -0.61 | -0.10 | -1.00 | -1.00 |
| Restricted Cash | — | 5000.00 | 0.22 Cr | 0.21 Cr | — |
| Prepaid Assets | — | 0.18 Cr | 0.01 Cr | 0.32 Cr | 0.14 Cr |
| Work In Process | — | 1.30 Cr | 3.10 Cr | 1.08 Cr | 1.51 Cr |
| Raw Materials | — | 1.10 Cr | 1.21 Cr | 1.77 Cr | 2.44 Cr |
| Cash Financial | — | 0.05 Cr | 0.19 Cr | 0.84 Cr | 2.55 Cr |
| Available For Sale Securities | — | — | 6000.00 | 6000.00 | 0.20 Cr |
| Finished Goods | — | — | — | — | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Parmax Pharma Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.